NDC 0002-2980 – Retevmo
Selpercatinib 80 mg/1 · Capsule · Oral
Product NDC0002-2980
Product details
- Brand name
- Retevmo
- Generic name
- selpercatinib
- Labeler
- Eli Lilly and Company
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA213246
- Marketed since
- May 8, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Selpercatinib 80 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0002-2980-26 | 120 CAPSULE in 1 BOTTLE (0002-2980-26) | May 8, 2020 |
| 0002-2980-60 | 60 CAPSULE in 1 BOTTLE (0002-2980-60) | May 8, 2020 |
Other Retevmo products
- 0002-3977 Selpercatinib 40 mg/1 · Capsule · Eli Lilly and Company
- 0002-5340 Selpercatinib 40 mg/1 · Tablet, Coated · Eli Lilly and Company
- 0002-5562 Selpercatinib 160 mg/1 · Tablet, Coated · Eli Lilly and Company
- 0002-6082 Selpercatinib 80 mg/1 · Tablet, Coated · Eli Lilly and Company
- 0002-6120 Selpercatinib 120 mg/1 · Tablet, Coated · Eli Lilly and Company